We are pleased to announce that “Innovation Norway” has offered Alv B a grant for the commercialization of Alv B’s product range within immunotherapy, and diagnostics for cats and dogs with cancer.
Innovation Norway is the Norwegian Government’s most important instrument for innovation and development of Norwegian enterprises and industry.
